MedcoEnergi Accelerates Sakakemang Block Production to 2027

PT Medco E&P Indonesia is demonstrating its commitment to bolstering national energy security through a strategic acceleration of its Sakakemang Block production timeline. The decision to bring forward the production target from the first quarter of 2028 to the third quarter of 2027 signifies a proactive approach to meeting Indonesia's growing energy demands.

This accelerated schedule is made possible by leveraging existing infrastructure and integrating it with facilities from MedcoEnergi's established Corridor and Gresik blocks. Senior VP Business Support Iwan Prajogi highlighted this integration as key to both speeding up production and optimizing costs, a crucial factor in the competitive energy landscape.

The Sakakemang Block, acquired by MedcoEnergi from Repsol in 2025, represents a significant addition to the company's portfolio. As the operator with a 45 percent participating interest, MedcoEnergi is poised to capitalize on this asset, which has already received development plan approval from the Indonesian government. Its proximity to the Corridor Block further enhances operational synergies in South Sumatra, where MedcoEnergi already manages three other blocks.

MedcoEnergi's performance in early 2026, with a 18 percent increase in oil and gas production to 170 mboepd, underscores its growing capacity and its vital role in ensuring a reliable energy supply for Indonesia's economic growth. The company's continued expansion, including the potential acquisition of the South Sakakemang Block, positions it as a key player in the nation's energy future.

“

With this, the time can be accelerated, and the costs can be reduced.